Psychomotor slowing (PS) is a cluster of symptoms that was already recognized in
schizophrenia by its earliest investigators. Nevertheless, few studies have been dedicated to …

Context Neurocognitive impairment in schizophrenia is severe and is an important predictor
of functional outcome. The relative effect of the second-generation (atypical) antipsychotic …

The purpose of this article is to discuss the prediction of cognitive enhancement in
schizophrenia from preclinical data. Despite increasing focus on the significance of cognitive …

An accumulating body of evidences point to the significance of neuroinflammation and
immunogenetics in schizophrenia, characterized by increased serum concentration of …

Guidelines for schizophrenia treatment have been created in various countries and have
been translated and used in Japan as well. However, the available drugs and their …

METHOD This 6-week, flexible-dose, open-label study was approved by the Institutional
Review Board of the Robert Wood Johnson Medical School. Subjects were required to be at …

Abstract Setting Treating elderly patients with Alzheimer's disease (AD) and behavioral and
psychological symptoms of dementia (BPSD) is challenging due to the increased risk of …

The digit span task measures the maintenance of information in short-term memory, and is
one of the most widely used tests in clinical and experimental neuropsychology. Functional …

Background Cognitive deficits are considered core symptoms of the schizophrenia.
Cognitive function has been found to be a better predictor of functional outcome than …

Schizophrenia is associated with impairments of attentional control on classic experimental
paradigms such as the Stroop task. However, at a basic level the neurochemical …